GlobeNewswire PharmaOriginal article
60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA
Data ReadoutPositive
AI Analysis
Summary
60 Degrees Pharmaceuticals announced it plans to release data from its hospitalized babesiosis trial in January 2027 and will seek a pre-sNDA meeting with the FDA to discuss regulatory pathway.
Clinical Trial Data
Importance:6/10
Sentiment:
0.50
clinical trialdata readoutbabesiosisFDA meetingpre-sNDA
Read the original article
Published by GlobeNewswire Pharma on October 6, 2026 12:10 PM